India's Divi's Labs drops on missing Q1 profit view
** Divi's Laboratories DIVI.NS drops 3% to 6,220 rupees; top loser on pharma index .NIPHARM, which is down 1.3% ** Drugmaker misses Q1 profit view on weak U.S. pricing for its drugs amid stiff competition ** Stock slumped as much as 4% after results; was down 2.5% ahead of results ** Stock rated "hold" on avg; median PT is 6,460 rupees, per data compiled by LSEG ** YTD, DIVI gains 2% vs NIPHARM's 7.4% decline (Reporting by Kashish Tandon in Bengaluru) ((Kashish.tandon@thomsonreuters.com))
Recent news on Divi's Laboratories
See all newsDivi's Laboratories and Laurus Labs lead India's record CRDMO growth, Jefferies says
India Stocks: Indian shares inch higher to close at 8-month high as crude oil drops
India's Divi's Laboratories jumps to record high after profit jumps by nearly two thirds
Indian shares muted as markets pause after last week's rally
India Stocks: Indian shares consolidate in Diwali session after seven-day rally